(Adnkronos) - "In Svezia l’impatto dei sacchetti di nicotina è stato importante: l’incidenza di malattie legate al fumo, come il tumore al polmone, è molto inferiore rispetto a quella di altri paesi europei”. Queste le parole di Patrik Hildingsson, Director oral category communication di Philip Morris International, al lancio in Italia dei sacchetti di nicotina ZYN, bustine di cellulosa, prive di tabacco, che non producono fumo, vapore, cenere o odore e pensate per essere una soluzione alternativa alla sigaretta tradizionale.
Category
🗞
NewsTranscript
00:00When it comes to smoking and reducing the harm of cigarette smoking, the first thing to do
00:14is to try to eliminate combustion, the combustion that is responsible for the production of chemical
00:20substances that are closely linked to many diseases from the consumption of smoke.
00:24By doing this, by eliminating combustion, the risks are greatly reduced.
00:29Talking instead of sachets, sachets with nicotine or sachets with tobacco, their impact has been huge
00:36in countries such as Sweden, the Swedish population.
00:39If we think of the incidence of diseases such as lung cancer and the national figures of the
00:45National Research Institute show that the incidence of diseases such as lung cancer in Sweden
00:51is 50% lower than in other European countries.
00:55We know how lung cancer is unfortunately a very common disease.
00:59In the world there are 1.2 billion smokers who could be interested in this, which is certainly
01:07a great job for us, but also a great opportunity, the opportunity that we offer to smokers
01:13to find alternatives, obviously smokers who do not intend to quit smoking.